[Number Page 1.1 Announcement, dated April 20, 2018 A-1 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansion and capital expenditure plans; • the expected im]
[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, April 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on EX-99.1 2 e]
[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, April 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on EX-99.1 2 e]
[FORM 20-F (Mark One) o OR x OR o For the transition period from to OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . CTRIP.COM INTERNATIONAL, LTD. N/A Cayman Islands (Jurisdiction of incorporation or organization) 968 Jin Zhong Road Shanghai] [TECHNICAL CON]
[FORM 20-F (Mark One) o OR x OR o For the transition period from to OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . CTRIP.COM INTERNATIONAL, LTD. N/A Cayman Islands (Jurisdiction of incorporation or organization) 968 Jin Zhong Road Shanghai] [TECHNICAL CON]
[Shenping Yin 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) ¨ (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED ¨ 6. CITIZENSHIP OR PLACE OF ORGANIZATION: P. R. China NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH]
[Shenping Yin 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) ¨ (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED ¨ 6. CITIZENSHIP OR PLACE OF ORGANIZATION: P. R. China NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH]
[Guangqiang Chen 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) ¨ (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED ¨ 6. CITIZENSHIP OR PLACE OF ORGANIZATION: P. R. China NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING]
[Sinovac Resumes Production and Operation at Sinovac Beijing’s Quality Assurance Department The successful resumption of regular production and operations at Sinovac Beijing’s Shangdi manufacturing facility follows the events of April 17, 2018, when Aihua Pan, the Chairman of the Board of Sinovac Bei]
[Sinovac Resumes Production and Operation at Sinovac Beijing’s Quality Assurance Department The successful resumption of regular production and operations at Sinovac Beijing’s Shangdi manufacturing facility follows the events of April 17, 2018, when Aihua Pan, the Chairman of the Board of Sinovac Bei]
